帕金森病药物治疗研究进展

被引:24
作者
林清 [1 ]
罗永杰 [2 ]
机构
[1] 西南医科大学
[2] 四川省医学科学院·四川省人民医院神经内科
关键词
帕金森病; 左旋多巴; 多巴胺受体兴奋剂; 单胺氧化酶抑制剂; 儿茶酚胺-氧位-甲基转移酶抑制剂;
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
1002 ;
摘要
目前帕金森病主要治疗药物有多巴类制剂、受体兴奋剂、单胺氧化酶B(MAO-B)抑制剂、儿茶酚胺-氧位-甲基转移酶(COMT)抑制剂等。帕金森病药物治疗虽然取得了一定进展,但这些药物不能阻止病情发展。本文对帕金森病的药物治疗进展进行综述。
引用
收藏
页码:86 / 89
页数:4
相关论文
共 15 条
[1]   帕金森病的药物治疗进展 [J].
司宏波 .
中国医药指南, 2014, 12 (14) :60-61
[2]  
帕金森病发病机制与治疗研究十年进展[J]. 汪锡金,张煜,陈生弟.中国现代神经疾病杂志. 2010(01)
[3]   罗替戈汀的药理作用与临床评价附视频 [J].
田艳平 ;
崔向丽 .
医药导报, 2009, (10) :1327-1328
[4]  
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson’s disease: A multicenter, double-blind, randomized, placebo-controlled study[J] . Zhenxin Zhang,Jian Wang,Xiaoying Zhang,Shengdi Chen,Zhenfu Wang,Baorong Zhang,Chunfeng Liu,Qiumin Qu,Yan Cheng,Jie Li,Haijun Cao,Meng Cai,Rongxuan Zhu.Parkinsonism and Related Disorders . 2013 (11)
[5]  
Integrated multidisciplinary care in Parkinson’s disease: a non-randomised, controlled trial (IMPACT)[J] . Marjolein A van der Marck,Marten Munneke,Wim Mulleners,Edo M Hoogerwaard,George F Borm,Sebastiaan Overeem,Bastiaan R Bloem.Lancet Neurology . 2013 (10)
[6]  
Inhaled dry powder apomorphine ( VR 040) for ‘off ’ periods in P arkinson’s disease: an in‐clinic double‐blind dose ranging study[J] . K. A. Grosset,N. Malek,F. Morgan,D. G. Grosset.Acta Neurol Scand . 2013 (3)
[7]  
Disease duration-related differences in non-motor symptoms: A study of 616 Chinese Parkinson’s disease patients[J] . Xiaoyan Guo,Wei Song,Ke Chen,XuePing Chen,Zhenzhen Zheng,Bei Cao,Rui Huang,Bi Zhao,Ying Wu,Hui-Fang Shang.Journal of the Neurological Sciences . 2013 (1-2)
[8]  
Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer’s, Parkinson’s and prion diseases[J] . John H. Viles.Coordination Chemistry Reviews . 2012 (19-2)
[9]  
Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases[J] . Wei Zheng,Andrew D. Monnot.Pharmacology and Therapeutics . 2011 (2)
[10]  
Effect of rotigotine on sleep and quality of life in Parkinson’s disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline[J] . Liesbet Ghys,Erwin Surmann,John Whitesides,Babak Boroojerdi.Expert Opinion on Pharmacotherapy . 2011 (13)